Biotech

Novo Nordisk

Biotech

ADA: Novo CSO says ‘jury still out’ on CagriSema v. retatrutide

It's too early to say whose next-gen incretin stands supreme between Novo Nordisk’s CagriSema and Eli Lilly’s retatrutide, Novo’s CSO told Fierce.

Fraiser Kansteiner Jun 10, 2026 11:10am

Brown mouse nibbling a cookie

GLP-1s may combat depression through a mood-boosting gut microbe

Jun 10, 2026 11:00am

How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate

Bubbles in boiling water

Big Pharma-backed SonoThera sounds off with $125M series B

Jun 10, 2026 10:48am

Managing complexity across biopharma modalities

Managing complexity across biopharma modalities

Brought to you by SK Pharmteco

dollar sign pipeline

Ethyreal Bio raises $101M, joining biotechs gunning for Tepezza

Jun 10, 2026 9:35am